Keel Point’s Guardant Health GH Stock Holding History

Keel Point’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Buy	2,320 +32	+1%	+$3.48K	0.02%	351
2026 Q1	$211K	Sell	2,288 -121	-5%	-$12.1K	0.01%	437
2025 Q4	$246K	Buy	+2,409	New	+$216K	0.01%	453

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Keel Point's GH Position: Q2 2026 in Review

Keel Point increased its Guardant Health (GH) stake by 1.4% in Q2 2026, buying an estimated $3.48K and bringing the position to 2,320 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #351.

Keel Point first reported a position in GH in Q4 2025 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Keel Point held 2,320 shares of Guardant Health worth $348K as of Q2 2026.
Keel Point bought 32 Guardant Health shares in Q2 2026, an estimated $3.48K.
Guardant Health made up 0.02% of Keel Point's portfolio in Q2 2026, its #351 holding.
Keel Point first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.